ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 32,706 followers.

New Research: Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy: Background Only a proportion of patients with bladder cancer may benefit from… https://t.co/fkYixS

04 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.